Table 5.
Recurrence rate and median recurrence-free survival (RFS) for Keyhole Limpet Hemocyanin (KLH) and mitomycin C (MM) in patients with recurrence and complete treatment course who received additional treatment after transurethral resection of bladder tumor (TURBT) for prior tumor (KLH second-line treatment)
Recurrence rate (%) | Median (weeks) | 95% confidence interval | ||
---|---|---|---|---|
Lower bound | Upper bound | |||
KLH | 48 | 235 | 35 | 435 |
Mitomycin C | 52 | 98 | 75 | 121 |
Overall | 50 | 210 | 69 | 351 |